Dr. Fritz will discuss signs and symptoms of PANS/Lyme and appropriate evaluation and treatment, including natural and pharmaceutical antimicrobials, immune modulating therapy, and an integrative...
This is an educational video about the autoimmune neuropsychiatric disorders, PANS and PANDAS. PANS, Pediatric Acute-onset Neuropsychiatric Syndrome and PANDAS, Pediatric Autoimmune Neuropsychiatric...
“PANDAS turned out to be the cause of new obsessive-compulsive symptoms in our son, who also has autism. But the lack of information and awareness left his symptoms untreated for nearly 3 years....
Dr. Sue Swedo - originator of the PANS/PANDAS diagnosis. Dr. Madeleine Cunningham of Moleculara Labs, and namesake to the Cunningham Panel - a test that helps aid the diagnosis of PANDAS. Dr. Nancy...
NE PANS/Parents Parents Association Conference November, 2013 Peggy Chapman discusses how to explain PANS/PANDAS to your child as well as behavioral interventions and psychiatric...
An Integrative Medicine Approach To Neuroimmune Disorders:...
NE PANS/PANDAS Parent Association Conference November 2013 Dr. Beth Latimer The Spectrum of PANDAS: One Size Does Not Fit...
A host of behaviors—OCD, Tourette’s, anxiety, depression, tics, eating disorders, hair pulling, bedwetting, mood swings—are often symptoms of an undiagnosed infection. The correct diagnosis is...
n a swift and breathtaking narrative, Susannah tells the astonishing true story of her descent into madness, her family’s inspiring faith in her, and the lifesaving diagnosis that nearly didn’t...
A significant portion of Lyme disease-treated patients experiences persistent symptoms for months or even years, including pain, fatigue, and neurocognitive issues, collectively referred to as post-treatment Lyme disease syndrome. Determining whether ongoing infection is present remains challenging with current technology, raising an open question. Alternatively, a post-infectious immune-mediated process could be responsible for sustained symptoms.
As fatigue and depression significantly impact the reported decline in both physical and mental functioning in patients with PTLDS, clinicians should thoroughly evaluate these symptoms. It is advisable to consider addressing these issues when selecting treatment interventions. Subsequent controlled studies should investigate the efficacy of such approaches for patients dealing with PTLDS.
Summary: Microbes, both pathogenic and commensal, can induce autoantibodies that bind to brain and affect behavior in susceptible hosts. Interventions that correct the microbial balance or diminish autoantibody binding may be effective in diverse neuropsychiatric conditions mediated by autoimmunity.